Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Proliferation as a natural strategy to suppress neoplasia.

Created on 19 Aug 2026

Authors

Anish A Sarma, Lea Goentoro, John Doyle

Published in

Proceedings of the National Academy of Sciences of the United States of America. Volume 123. Issue 34. Pages e2605763123. Aug 25, 2026. Epub Aug 18, 2026.

Abstract

Cell proliferation is necessary to maintain tissue homeostasis, but proliferation carries with it a risk of cancer. To understand how some organisms suppress cancer while maintaining homeostasis, we developed a dynamical model of cell populations. The model identifies two regimes. In one regime, as expected, proliferation drives accumulation of neoplastic cells. In another regime, unexpectedly, increasing proliferation suppresses accumulation of neoplastic cells. In this regime, as more cells proliferate, more cells also die as a consequence of homeostatic feedback. As long as neoplastic cells are targeted preferentially, the high flux effectively acts as a proofreader. High-flux proofreading works even when the system lacks a highly specific detector of neoplastic cells. As a first experimental test, we examined the jellyfish. Neoplasms are rarely observed in cnidarians, yet simply inhibiting proliferation promotes neoplasms. The quantitative framework developed here offers experimentally testable predictions to assess high-flux proofreading in other systems.

PMID:
42612004
Bibliographic data and abstract were imported from PubMed on 19 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 17
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement